Adicet Bio Stock Buy Hold or Sell Recommendation
| ACET Stock | USD 2.10 0.10 5.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Adicet Bio is 'Cautious Hold'. Macroaxis provides Adicet Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ACET positions. The advice algorithm takes into account all of Adicet Bio's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Adicet Bio's buy or sell advice are summarized below:
Real Value 6.57 | Target Price 20.33 | Hype Value 1.98 | Market Value 2.1 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Adicet Bio given historical horizon and risk tolerance towards Adicet Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Adicet Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Adicet |
Execute Adicet Bio Buy or Sell Advice
The Adicet recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Adicet Bio. Macroaxis does not own or have any residual interests in Adicet Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Adicet Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Adicet Bio Trading Alerts and Improvement Suggestions
| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio has high historical volatility and very poor performance | |
| Net Loss for the year was (142.66 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 68.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Adicet Bio, Inc. Short Interest Update - MarketBeat |
Adicet Bio current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Adicet analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Adicet analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Adicet Bio Returns Distribution Density
The distribution of Adicet Bio's historical returns is an attempt to chart the uncertainty of Adicet Bio's future price movements. The chart of the probability distribution of Adicet Bio daily returns describes the distribution of returns around its average expected value. We use Adicet Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Adicet Bio returns is essential to provide solid investment advice for Adicet Bio.
| Mean Return | -0.2 | Value At Risk | -8.89 | Potential Upside | 5.30 | Standard Deviation | 4.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Adicet Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Adicet Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Adicet Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adicet Bio backward and forwards among themselves. Adicet Bio's institutional investor refers to the entity that pools money to purchase Adicet Bio's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2023-12-31 | 661.8 K | State Street Corporation | 2023-12-31 | 640.5 K | Acadian Asset Management Llc | 2023-12-31 | 559.8 K | Two Sigma Advisers, Llc | 2023-12-31 | 520 K | Norges Bank | 2023-12-31 | 429.6 K | Two Sigma Investments Llc | 2023-12-31 | 360.7 K | Jacobs Levy Equity Management, Inc. | 2023-09-30 | 333.6 K | D. E. Shaw & Co Lp | 2023-09-30 | 244.9 K | Northern Trust Corp | 2023-12-31 | 232.1 K | Orbimed Advisors, Llc | 2023-12-31 | 8.3 M | Rtw Investments, Llc | 2023-12-31 | 4.1 M |
Adicet Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.1M | 74.0M | 188.8M | (20.0M) | (97.9M) | (93.0M) | |
| Free Cash Flow | (29.0M) | (42.5M) | (64.1M) | (61.5M) | (98.2M) | (93.3M) | |
| Depreciation | 1.2M | 1.2M | 1.5M | 2.6M | 6.1M | 4.2M | |
| Other Non Cash Items | (2.5M) | (1.0M) | 1.7M | 2.6M | 56.5M | 59.3M | |
| Capital Expenditures | 1.1M | 990K | 13.0M | 16.8M | 4.5M | 3.7M | |
| Net Income | (28.1M) | (36.7M) | (62.0M) | (69.8M) | (142.7M) | (135.5M) | |
| End Period Cash Flow | 14.9M | 88.9M | 277.7M | 257.7M | 159.7M | 84.8M |
Adicet Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adicet Bio or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adicet Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adicet stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.38 | |
β | Beta against NYSE Composite | 2.15 | |
σ | Overall volatility | 4.75 | |
Ir | Information ratio | -0.06 |
Adicet Bio Volatility Alert
Adicet Bio exhibits very low volatility with skewness of 0.54 and kurtosis of 3.36. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Adicet Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Adicet Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Adicet Bio Fundamentals Vs Peers
Comparing Adicet Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Adicet Bio's direct or indirect competition across all of the common fundamentals between Adicet Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Adicet Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Adicet Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Adicet Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Adicet Bio to competition |
| Fundamentals | Adicet Bio | Peer Average |
| Return On Equity | -0.62 | -0.31 |
| Return On Asset | -0.31 | -0.14 |
| Current Valuation | 25.52 M | 16.62 B |
| Shares Outstanding | 82.15 M | 571.82 M |
| Shares Owned By Insiders | 1.42 % | 10.09 % |
| Shares Owned By Institutions | 68.02 % | 39.21 % |
| Number Of Shares Shorted | 7.69 M | 4.71 M |
| Price To Earning | 36.84 X | 28.72 X |
| Price To Book | 1.04 X | 9.51 X |
| Price To Sales | 9.72 X | 11.42 X |
| Gross Profit | 24.99 M | 27.38 B |
| EBITDA | (126.48 M) | 3.9 B |
| Net Income | (142.66 M) | 570.98 M |
| Cash And Equivalents | 260.64 M | 2.7 B |
| Cash Per Share | 6.11 X | 5.01 X |
| Total Debt | 20.92 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 16.10 X | 2.16 X |
| Book Value Per Share | 3.93 X | 1.93 K |
| Cash Flow From Operations | (93.72 M) | 971.22 M |
| Short Ratio | 5.24 X | 4.00 X |
| Earnings Per Share | (3.31) X | 3.12 X |
| Price To Earnings To Growth | 0.82 X | 4.89 X |
| Target Price | 9.0 | |
| Number Of Employees | 143 | 18.84 K |
| Beta | 1.62 | -0.15 |
| Market Capitalization | 164.31 M | 19.03 B |
| Total Asset | 207.29 M | 29.47 B |
| Retained Earnings | (380.77 M) | 9.33 B |
| Working Capital | 142.99 M | 1.48 B |
| Current Asset | 352.66 M | 9.34 B |
| Current Liabilities | 98.91 M | 7.9 B |
| Five Year Return | 3.23 % |
Note: Acquisition by Schor Chen of 240000 shares of Adicet Bio subject to Rule 16b-3 [view details]
Adicet Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Adicet . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 90434.24 | |||
| Daily Balance Of Power | 0.5556 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 2.16 | |||
| Day Typical Price | 2.14 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | 0.1 |
About Adicet Bio Buy or Sell Advice
When is the right time to buy or sell Adicet Bio? Buying financial instruments such as Adicet Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 20.9M | 21.0M | 20.9M | 19.9M | Total Assets | 338.9M | 330.7M | 207.3M | 363.6M |
Use Investing Ideas to Build Portfolios
In addition to having Adicet Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Coal Thematic Idea Now
Coal
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Adicet Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Adicet Stock analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.31) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.62) |
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.